TV commercials are starting to pop up from Pfizer to get your booster. Umm, no.
Yeah, listening to Pfizer and Fraudci is a pretty bad habit.
The preprint observational study using U.K. health system data also found the Pfizer-BioNTech COVID-19 vaccine provided children and teens with only about 14 to 15 weeks of protection against testing positive for the virus.
The Pfizer-BioNTech COVID-19 vaccine provided children and teens in England with only about 14 to 15 weeks of protection against testing positive for the virus, according to a
preprint study of over 1.7 million children ages 5 to 15 in the English National Healthcare System (NHS).
Researchers investigating the safety and effectiveness of Pfizer’s vaccine in fully vaccinated, partially vaccinated, and unvaccinated children and teens,
also found cases of myocarditis and pericarditis only in vaccinated children...
The study found that vaccinated children required slightly fewer emergency room visits and hospital stays, but that those outcomes were extremely rare in children and teens across all groups.
There were no
COVID-19 deaths among any of the study subjects...
The research also confirmed that even in 2021, when the vaccine was first authorized for children and teens, that age group did not face a high risk for COVID-19-related serious outcomes, including death or the need for emergency care, hospitalization or critical care...
They tested for five measures of effectiveness — a positive COVID-19 test, visits to the emergency department, COVID-19 hospitalization, COVID-19 critical care admission and death from COVID-19.
In total, 410,463 teenagers who received one dose of the vaccine were matched to unvaccinated controls, and 220,929 adolescents who received two shots were matched to single-vaccinated controls.
Of the 1,262,784 children in the adolescent part of the study — vaccinated and unvaccinated — there were only 72 emergency room visits, 90 COVID-19 hospitalizations — three of which were critical care for unvaccinated children — and no deaths.
There were nine cases of pericarditis and three cases of myocarditis, all in the vaccinated group.
Initially, positive COVID-19 tests were lower in the vaccinated group. However, by 15 weeks post-vaccination, the rates of positive tests in both groups were similar. The incidence of needing either emergency care or hospitalization was slightly lower in the vaccinated group.
Similarly in the two-dose to one-dose comparison, the incidence of positive tests was initially lower in the first group, but by 14 weeks post-vaccination was about the same in both groups...
They concluded that in adolescents, the vaccine reduced the rate of hospitalization more than it increased the risk for myocarditis and pericarditis, but for children, the increased risk of pericarditis was higher than the reduction of risk for hospitalization.